NEW YORK, Aug. 29, 2021 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Orphazyme A/S (NASDAQ: ORPH): (1) pursuant and/or traceable to Orphazyme’s September 29, 2020 initial public offering (the “IPO” or “Offering”); and/or (2) between September 29, 2020 and June 18, 2021, inclusive, (the “Class Period”) of the important September 7, 2021 lead plaintiff deadline in the securities class action. SO WHAT: If you purchased Orphazyme securities pursuant and/or traceable to the IPO and/or Orphazyme securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
